Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Edgewise Therapeutics Inc...

    NASDAQ: EWTX · Real-Time Price · USD
    14.66
    -0.63 (-4.12%)
    At close: Jun 16, 2025, 3:59 PM
    14.69
    0.17%
    After-hours: Jun 16, 2025, 05:49 PM EDT

    Edgewise Therapeutics Statistics

    Share Statistics

    Edgewise Therapeutics has 105.2M shares outstanding. The number of shares has increased by 1.93% in one year.

    Shares Outstanding

    n/a
    		 105.2M

    Shares Change (YoY)

    n/a
    		 1.93%

    Shares Change (QoQ)

    n/a
    		 0.55%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 77.1M

    Failed to Deliver (FTD) Shares

    n/a
    		 4,749

    FTD / Avg. Volume

    n/a
    		 0.28%

    Short Selling Information

    The latest short interest is 14.31M, so 13.6% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 14.31M

    Short % of Shares Out

    n/a
    		 13.6%

    Short % of Float

    n/a
    		 15.97%

    Short Ratio (days to cover)

    n/a
    		 14.31

    Valuation Ratios

    The PE ratio is -18.44 and the forward PE ratio is -8.01. Edgewise Therapeutics's PEG ratio is 2.41.

    PE Ratio

    n/a
    		 -18.44

    Forward PE

    n/a
    		 -8.01

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 3

    PB Ratio

    n/a
    		 5.37

    P/FCF Ratio

    n/a
    		 -22.36

    PEG Ratio

    n/a
    		 2.41
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Edgewise Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 19.93, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 19.93

    Quick Ratio

    n/a
    		 19.93

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.04

    Debt / FCF

    n/a
    		 -0.04

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,143,700.85

    Employee Count

    n/a
    		 117

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -15.6% in the last 52 weeks. The beta is 0.29, so Edgewise Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.29

    52-Week Price Change

    n/a
    		 -15.6%

    50-Day Moving Average

    n/a
    		 14.38

    200-Day Moving Average

    n/a
    		 24.32

    Relative Strength Index (RSI)

    n/a
    		 45.71

    Average Volume (20 Days)

    n/a
    		 1,704,495

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -158.83M

    Net Income

    n/a
    		 -133.81M

    EBITDA

    n/a
    		 -131.52M

    EBIT

    n/a
    		 -133.81M

    Earnings Per Share (EPS)

    n/a
    		 -1.45
    Full Income Statement

    Balance Sheet

    The company has 41.67M in cash and 4.74M in debt, giving a net cash position of 36.93M.

    Cash & Cash Equivalents

    n/a
    		 41.67M

    Total Debt

    n/a
    		 4.74M

    Net Cash

    n/a
    		 36.93M

    Retained Earnings

    n/a
    		 -378.58M

    Total Assets

    n/a
    		 454.39M

    Working Capital

    n/a
    		 422.06M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -109.03M and capital expenditures -1.31M, giving a free cash flow of -110.34M.

    Operating Cash Flow

    n/a
    		 -109.03M

    Capital Expenditures

    n/a
    		 -1.31M

    Free Cash Flow

    n/a
    		 -110.34M

    FCF Per Share

    n/a
    		 -1.19
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    EWTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for EWTX is $45.5, which is 210.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $45.5

    Price Target Difference

    n/a
    		 210.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 34.38

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist